Company Filing History:
1 out of 832,912 Years Active: 2000
Title: Julie Gauthier: Innovator in Diagnostic and Therapeutic Applications
Introduction
Julie Gauthier is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of mental health through her innovative research and inventions. Her work focuses on identifying and addressing Syngap1 dysfunctions, which are linked to mental retardation.
Latest Patents
Julie Gauthier holds a patent titled "Syngap1 Dysfunctions And Uses Thereof In Diagnostic And Therapeutic Applications For Mental Retardation." This invention identifies Syngap1 dysfunctions as causative factors of mental retardation. The patent describes methods for detecting mental retardation and non-syndromic mental retardation (NSMR) in human subjects. Specific methods include sequencing a human subject's genomic DNA for comparison with a control sequence from an unaffected individual. Additionally, the patent outlines probes, kits, antibodies, and isolated mutated Syngap1 proteins.
Career Highlights
Throughout her career, Julie Gauthier has worked at notable institutions, including the Centre Hospitalier Universitaire Sainte-Justine and the Centre Hospitalier de l'Université de Montréal. Her research has been instrumental in advancing the understanding of genetic factors related to mental health.
Collaborations
Julie has collaborated with esteemed colleagues such as Jacques Michaud and Fadi Hamdan. Their combined expertise has contributed to the development of innovative diagnostic methods and therapeutic applications.
Conclusion
Julie Gauthier is a trailblazer in the field of mental health diagnostics and therapeutics. Her work on Syngap1 dysfunctions has the potential to significantly impact the lives of individuals affected by mental retardation.